Although autophagy activation associated with p53 status is considered crucial in cancer therapy [46,47], the molecular mechanisms underlying the inhibition of tumor autophagy due to miR-30a elevation, which improves drug sensitivity, are explored as potent suppressors of cancer cell progression. Here, TP53 is linked to neoplasm.